Abstract 5030: The impact of ABCB1 single nucleotide polymorphisms on the outcome in lenalidomide treated multiple myeloma patients

MLA

Johan Lund, et al. “Abstract 5030: The Impact of ABCB1 Single Nucleotide Polymorphisms on the Outcome in Lenalidomide Treated Multiple Myeloma Patients.” Cancer Research, vol. 77, July 2017, p. 5030. EBSCOhost, https://doi.org/10.1158/1538-7445.am2017-5030.

APA

Johan Lund, Astrid Gruber, Birgitta Lauri, Karin Forsberg, Mats Hardling, Agneta Swedin, Lucia Ahlberg, Kourosh Lotfi, Henrik Gréen, Hareth Nahi, Cecilie Blimark, Ulf-Henrik Mellqvist, Ingrid Jakobsen Falk, Evren Alici, & Conny Carlsson. (2017). Abstract 5030: The impact of ABCB1 single nucleotide polymorphisms on the outcome in lenalidomide treated multiple myeloma patients. Cancer Research, 77, 5030. https://doi.org/10.1158/1538-7445.am2017-5030

Chicago

Johan Lund, Astrid Gruber, Birgitta Lauri, Karin Forsberg, Mats Hardling, Agneta Swedin, Lucia Ahlberg, et al. 2017. “Abstract 5030: The Impact of ABCB1 Single Nucleotide Polymorphisms on the Outcome in Lenalidomide Treated Multiple Myeloma Patients.” Cancer Research 77 (July): 5030. doi:10.1158/1538-7445.am2017-5030.